Table 1:
Characteristic | Individuals without schizophrenia | Individuals with schizophrenia | ||||
---|---|---|---|---|---|---|
|
|
|||||
No. (%) of deaths | Population 15–105 yr, no. (%) | Crude rate per 1000 (95% CI) | No. (%) of deaths | Population 15–105 yr, no. (%) | Crude rate per 1000 (95% CI) | |
Overall | 72 068 (100) | 8 793 478 (100) | 8.20 (8.14–8.26) | 830 (100) | 34 338 (100) | 24.17 (22.55–25.87) |
| ||||||
Age group, yr | ||||||
| ||||||
15–24 | 732 (1.0) | 1 494 489 (17.0) | 0.49 (0.45–0.53) | 13 (1.6) | 2240 (6.5) | 5.80 (3.09–9.92) |
| ||||||
25–34 | 1265 (1.8) | 1 943 429 (22.1) | 0.65 (0.62–0.69) | 62 (7.5) | 7991 (23.3) | 7.76 (5.95–9.95) |
| ||||||
35–44 | 2320 (3.2) | 1 768 768 (20.1) | 1.31 (1.26–1.37) | 71 (8.6) | 8782 (25.6) | 8.08 (6.31–10.2) |
| ||||||
45–54 | 3839 (5.3) | 1 292 297 (14.7) | 2.97 (2.88–3.07) | 79 (9.5) | 5751 (16.7) | 13.74 (10.88–17.12) |
| ||||||
55–64 | 8210 (11.4) | 954 048 (10.8) | 8.61 (8.42–8.79) | 115 (13.9) | 3969 (11.6) | 28.97 (23.92–34.78) |
| ||||||
65–74 | 16 888 (23.4) | 794 052 (9.0) | 21.27 (20.95–21.59) | 208 (25.1) | 3357 (9.8) | 61.96 (53.83–70.98) |
| ||||||
75–84 | 21 607 (30.0) | 408 679 (4.6) | 52.87 (52.17–53.58) | 195 (23.5) | 1669 (4.9) | 116.84 (101.01–134.44) |
| ||||||
≥ 85 | 17 207 (23.9) | 137 716 (1.6) | 124.95 (123.09–126.83) | 87 (10.5) | 579 (1.7) | 150.26 (120.35–185.34) |
| ||||||
Sex | ||||||
| ||||||
Female | 34 663 (48.1) | 4 495 701 (51.1) | 7.71 (7.63–7.79) | 461 (55.5) | 16 548 (48.2) | 27.86 (25.37–30.52) |
| ||||||
Male | 37 405 (51.9) | 4 297 777 (48.9) | 8.70 (8.62–8.79) | 369 (44.5) | 17 790 (51.8) | 20.74 (18.68–22.97) |
| ||||||
Neighbourhood income quintile | ||||||
| ||||||
Q1 (lowest) | 16 530 (22.9) | 1 820 592 (20.7) | 9.08 (8.94–9.22) | 187 (22.5) | 10 487 (30.5) | 17.83 (15.37–20.58) |
| ||||||
Q2 | 13 983 (19.4) | 1 701 129 (19.3) | 8.22 (8.08–8.36) | 158 (19.0) | 6884 (20.0) | 22.95 (19.51–26.82) |
| ||||||
Q3 | 12 399 (17.2) | 1 664 712 (18.9) | 7.45 (7.32–7.58) | 139 (16.7) | 5672 (16.5) | 24.51 (20.60–28.94) |
| ||||||
Q4 | 11 621 (16.1) | 1 675 344 (19.1) | 6.94 (6.81–7.06) | 108 (13.0) | 4670 (13.6) | 23.13 (18.97–27.92) |
| ||||||
Q5 (highest) | 11 840 (16.4) | 1 654 467 (18.8) | 7.16 (7.03–7.29) | 118 (14.2) | 4380 (12.8) | 26.94 (22.30–32.26) |
| ||||||
Unknown | 5695 (7.9) | 277 234 (3.2) | 20.54 (20.01–21.08) | 120 (14.5) | 2245 (6.5) | 53.45 (44.32–63.92) |
| ||||||
Dwelling | ||||||
| ||||||
Urban | 59 822 (83.0) | 7 322 674 (83.3) | 8.17 (8.10–8.24) | 714 (86.0) | 30 443 (88.7) | 23.45 (21.76–25.24) |
| ||||||
Rural | 11 727 (16.3) | 1 411 045 (16.0) | 8.31 (8.16–8.46) | 110 (13.3) | 3617 (10.5) | 30.41 (24.99–36.65) |
| ||||||
Unknown | 519 (0.7) | 59 759 (0.7) | 8.68 (7.95–9.47) | 6 (0.7) | 278 (0.8) | 21.58 (7.92–46.98) |
| ||||||
Cause of death*† | ||||||
| ||||||
Circulatory | 28 902 (40.1) | 8 793 478 (100) | 3.29 (3.25–3.32) | 238 (28.7) | 34 338 (100) | 6.93 (6.08–7.87) |
| ||||||
Neoplasm | 20 494 (28.4) | 8 793 478 (100) | 2.33 (2.30–2.36) | 145 (17.5) | 34 338 (100) | 4.22 (3.56–4.97) |
| ||||||
Metabolic‡ | 5090 (7.1) | 8 793 478 (100) | 0.58 (0.56–0.59) | 68 (8.2) | 34 338 (100) | 1.98 (1.54–2.51) |
| ||||||
Respiratory | 6153 (8.5) | 8 793 478 (100) | 0.70 (0.68–0.72) | 98 (11.8) | 34 338 (100) | 2.85 (2.32–3.48) |
| ||||||
Accidental§ | 2815 (3.9) | 8 793 478 (100) | 0.32 (0.31–0.33) | 49 (5.9) | 34 338 (100) | 1.43 (1.06–1.89) |
| ||||||
Suicide | 1012 (1.4) | 8 793 478 (100) | 0.12 (0.11–0.12) | 100 (12) | 34 338 (100) | 2.91 (2.37–3.54) |
Note: CI = confidence interval.
For a classification of International Classification of Diseases, 9th Revision codes into cause-of-death categories, see Appendix 1 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.161351/-/DC1).
Proportions for causes of death do not sum to 100% because some data were suppressed, as a result of small cell sizes.
Metabolic causes of death included metabolic, nutritional, immunity and endocrine conditions, as well as diseases of the digestive system.
Accidental causes of death included motor vehicle crashes, accidental poisoning, falls, fire, and drugs or adverse events in therapeutic use.